Jonathan Watanabe, PharmD, MS, PhD
Professor
Clinical Pharmacy
School of Pharmacy
Awards
Show all (21) Hide
- George F. Archambault Award, American Society of Consultant Pharmacists. Leading global organization for geriatric pharmacy, 2025
- UC Irvine Institute for Precision Health Distinguished Lecture. Inaugural Distinguished Lecture Speaker, UC Irvine, Institute for Precision Health, 2024
- 6th Annual California Institute for Regenerative Medicine Meeting (CIRM) Alpha Clinic Network, Keynote Speaker, California Institute for Regenerative Medicine Meeting (CIRM), 2023
- Keynote Speaker, Chapman University School of Pharmacy Research Day, Chapman University School of Pharmacy, 2021
- Peter P. Lamy Memorial Lecture Award. Keynote Speaker and Award recipient at American Society of Consultant Pharmacists Annual Meeting., Peter Lamy Center on Drug Therapy and Aging at the University of Maryland., 2021
- PhRMA Foundation inaugural Value Assessment Challenge Award Paper, PhRMA Foundation, 2020
- White-Coat Keynote Speaker, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences Class of 2024, UC San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 2020
- Distinguished Fellow, Get the Medications Right Institute., Get the Medications Right Institute. Tysons Corner, VA., 2019-Pres
- Forum on Drug Discovery, Development, and Translation of the National Academies of Sciences, Engineering, and Medicine. Appointed Member. Reappointed 2023-2026., National Academies of Sciences, Engineering, and Medicine Health and Medicine Division, 2019
- "Alumni Legend" Selection. One of initial five graduates selected for the University of Washington School of Pharmacy 125th Anniversary Celebration Awards Program., University of Washington Pharmacy Alumni Association, 2019
- Distinguished Alumni of the Year Award for Excellence in Pharmaceutical Sciences, University of Washington Pharmacy Alumni Association, 2019
- National Academy of Medicine Emerging Leaders in Health and Medicine Program Scholar, National Academy of Medicine Council, 2018-2021
- Gold Medal Research Poster Award. Academy of Managed Care Pharmacy (AMCP) Annual Meeting., Academy of Managed Care Pharmacy (AMCP), 2017
- Faculty-in-Residence. UC San Diego Cross-Cultural Center., UC San Diego Cross-Cultural Center., 2017
- National Institutes of Health (NIH) Loan Repayment Program Recipient., NIH, National Institute on Aging, 2016-2018
- National Academy of Medicine (formerly the Institute of Medicine) Anniversary Fellow in Pharmacy., National Academies of Medicine. Sponsored by American Association of Colleges of Pharmacy and American College of Clinical Pharmacy, 2016-2018
- Platinum Award for Top Research Abstract. Academy of Managed Care Pharmacy (AMCP) Nexus Conference. Boston, MA., Academy of Managed Care Pharmacy, 2014
- President's Research Initiative Award, American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting., American Association of Neuromuscular and Electrodiagnostic Medicine, 2010
- Inductee, Phi Lambda Sigma, National Pharmacy Leadership Society., Phi Lambda Sigma, National Pharmacy Leadership Society., 2007-Pres
- Harold Miller Leadership Award, University of Southern California School of Pharmacy, 2007
- Distinguished Service Award, University of Southern California School of Pharmacy, 2006
Education & Training
Show all (6) Hide
- Board Certification in Geriatric Pharmacy (BCGP) Board of Pharmacy Specialties
- PharmD Pharmacy University of Southern California, School of Pharmacy
- BS Zoology University of Washington
- MS Pharmaceutical Outcomes, Research, and Policy University of Washington, School of Pharmacy, Comparative Health, Outcomes, Policy, and Economics (CHOICE) Institute
- PhD Pharmaceutical Outcomes, Research, and Policy University of Washington, School of Pharmacy, Comparative Health, Outcomes, Policy, and Economics (CHOICE) Institute
- Health Economics and Outcomes Research University of Washington/Allergan Global Health Economics and Outcomes Research Fellowship
Publications (75)
Top publication keywords:
Prescription DrugsDrug EvaluationHospitalizationPharmacyDrug-Related Side Effects and Adverse ReactionsPharmacistsCholinergic AntagonistsOpioid-Related DisordersPolypharmacyHypoglycemic AgentsPharmaceutical ServicesHydroxymethylglutaryl-CoA Reductase InhibitorsGlucagon-Like Peptide-1 ReceptorMedication Therapy ManagementGlucagon-Like Peptides
-
Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape.
Journal of diabetes 2025 Hou W, Tuttle KR, Shen W, Reikes A, Watanabe JH -
Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022.
Journal of the American Pharmacists Association : JAPhA 2023 Watanabe JH, Kwon J, Nan B, Reikes A -
Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US.
JAMA health forum 2022 Qato DM, Watanabe JH, Clark KJ -
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
JAMA network open 2021 Watanabe JH, Kwon J, Nan B, Abeles SR, Jia S, Mehta SR -
Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.
Journal of the American Geriatrics Society 2018 Watanabe JH, Chau DL, Hirsch JD -
Cost of Prescription Drug-Related Morbidity and Mortality.
The Annals of pharmacotherapy 2018 Watanabe JH, McInnis T, Hirsch JD -
Making Medicines Affordable: A National Imperative
Making Medicines Affordable: A National Imperative 2017 -
Medication Use, Falls, and Fall-Related Worry in Older Adults in the United States.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2016 Watanabe JH -
Definition and Classification of Generic Drugs Across the World.
Applied health economics and health policy 2015 Alfonso-Cristancho R, Andia T, Barbosa T, Watanabe JH -
Approach to addressing missing data for electronic medical records and pharmacy claims data research.
Pharmacotherapy 2015 Bounthavong M, Watanabe JH, Sullivan KM -
Revisiting the medication possession ratio threshold for adherence in lipid management.
Current medical research and opinion 2013 Watanabe JH, Bounthavong M, Chen T
Show all (64 more) Hide
-
Off-label policy through the lens of trazodone usage and spending in the United States.
Health affairs scholar 2025 Kadiyala S, Chenoweth M, Watanabe JH -
Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database.
Expert review of endocrinology & metabolism 2025 Kwon J, Thiara D, Watanabe JH -
ASHP and ASHP Foundation Pharmacy Forecast 2025: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2025 DiPiro JT, Hoffman JM, Tichy E, Shea S, Sanborn M, Hung A, Fox ER, Watanabe JH, Torrise V, Abourjaily P, Cunningham FE, Schweitzer P, Nelson SD, Stump LS, Castro H, Nesbit TW, Scott CM -
Examining the impact of Anticholinergic Burden on Hospitalized Older People Receiving Concomitant Cholinesterase inhibitors.
The Senior care pharmacist 2024 Guan J, Noviasky J, Watanabe JH -
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities 2024 -
Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop
Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop 2024 -
Enhancing drug evaluation in diverse populations and older adults: National Academies of Sciences, Engineering, and Medicine considerations.
Journal of the American Geriatrics Society 2024 Watanabe JH -
Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States.
Pharmacy (Basel, Switzerland) 2024 Strand MW, Watanabe JH -
Aspirin Use in Older People Highlights the Need for Improved Inclusion of Older People in Clinical Trials.
The Senior care pharmacist 2024 Watanabe JH, Zajac D -
Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks
Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks 2024 -
Association of Pre-Pandemic Telehealth With Emergency Department and Telehealth Usage During the Pandemic.
The Senior care pharmacist 2024 Strand M, Watanabe JH -
Considerations on the Weight Loss-Associated Glucagon-like Peptide-1 Receptor Agonists for Older People.
The Senior care pharmacist 2023 Watanabe JH -
Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare-Medicaid Populations in a Historic Database.
Pharmacy (Basel, Switzerland) 2023 Watanabe JH, Hoang T -
Improving Care for Opioid Use Disorder in Nursing Facilities.
The Senior care pharmacist 2023 Watanabe JH -
Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review.
Journal of the American Pharmacists Association : JAPhA 2023 Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH -
Research with Pregnant and Lactating Persons: Mitigating Risk and Liability: Proceedings of a Workshop—in Brief
Research with Pregnant and Lactating Persons: Mitigating Risk and Liability: Proceedings of a Workshop—in Brief 2023 -
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States.
PharmacoEconomics - open 2023 Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH -
The Critical Role of Pharmacists in Treating Older People in the Opioid Crisis.
The Senior care pharmacist 2023 Watanabe JH -
Minding the gap and the value of metrics: Count of working pharmacists in the United States.
Journal of the American Pharmacists Association : JAPhA 2022 Hirsch JD, Nguyen MH, Abugazia J, Watanabe JH -
Responding to "Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People".
The Senior care pharmacist 2022 Khartabil N, Watanabe JH -
Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop
Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop 2022 -
Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People.
The Senior care pharmacist 2022 Watanabe JH -
Effects of financial toxicity on prescription drug use and mental well-being in cancer patients.
Exploratory research in clinical and social pharmacy 2022 Chan K, Sepassi A, Saunders IM, Goodman A, Watanabe JH -
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large Statewide Health System During the Pandemic in 2020.
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians 2022 Watanabe JH, Kwon J, Nan B, Abeles SR, Mehta SR -
Risk of Negative Health Outcomes and High Costs for People With Diabetes and Unmet Psychological Needs in the United States.
Diabetes spectrum : a publication of the American Diabetes Association 2022 Sepassi A, Bounthavong M, Singh RF, Heyman M, Beizai K, Watanabe JH -
Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop
Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop 2021 -
Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States.
Pharmacy (Basel, Switzerland) 2021 Luli AJ, Awdishu L, Hirsch JD, Watanabe JH, Bounthavong M, Morello CM -
Association of Age and Hospitalization Amongst Those with Underlying High-risk Conditions at COVID-19 Diagnosis in a Large, State-wide Health System.
Journal of general internal medicine 2021 Watanabe JH, Kwon J, Mehta SR -
When Can We Trust Real-World Data To Evaluate New Medical Treatments?
Clinical pharmacology and therapeutics 2021 Simon GE, Bindman AB, Dreyer NA, Platt R, Watanabe JH, Horberg M, Hernandez A, Califf RM -
When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?
Clinical pharmacology and therapeutics 2021 Simon GE, Platt R, Watanabe JH, Bindman AB, John London A, Horberg M, Hernandez A, Califf RM -
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
Clinical pharmacology and therapeutics 2021 Franklin JM, Platt R, Dreyer NA, London AJ, Simon GE, Watanabe JH, Horberg M, Hernandez A, Califf RM -
When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?
Clinical pharmacology and therapeutics 2021 Watanabe JH, Simon GE, Horberg M, Platt R, Hernandez A, Califf RM -
DISCARDED MEDICATIONS IN VIALS ARE A SYMPTOM OF OUR HEALTH CARE SYSTEM: A CALL TO ACTION.
Journal of managed care & specialty pharmacy 2021 Watanabe JH, Lieu T, Shortliffe EH -
Medications in Single-Dose Vials: Implications of Discarded Drugs
Medications in Single-Dose Vials: Implications of Discarded Drugs 2021 -
Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 Brasky TM, Flores KF, Larson JC, Newton AM, Shadyab AH, Watanabe JH, Lane DS, Thomson CA, LaCroix AZ -
Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population.
Journal of managed care & specialty pharmacy 2021 Kazerooni R, Watanabe JH -
Drug Research and Development for Adults Across the Older Age Span: Proceedings of a Workshop
Drug Research and Development for Adults Across the Older Age Span: Proceedings of a Workshop 2021 -
Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States.
Expert review of pharmacoeconomics & outcomes research 2020 Watanabe JH -
Association of combination opioid, benzodiazepine, and muscle relaxant usage with emergency department visits in a nationwide cohort in the United States.
International journal of clinical pharmacy 2020 Watanabe JH, Yang J -
Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder.
Journal of the American Pharmacists Association : JAPhA 2019 Luli AJ, Bounthavong M, Watanabe JH -
Hospitalization and Combined Use of Opioids, Benzodiazepines, and Muscle Relaxants in the United States.
Hospital pharmacy 2019 Watanabe JH, Yang J -
Advancing Pharmacist Collaborative Care within Academic Health Systems.
Pharmacy (Basel, Switzerland) 2019 Awdishu L, Singh RF, Saunders I, Yam FK, Hirsch JD, Lorentz S, Atayee RS, Ma JD, Tsunoda SM, Namba J, Mnatzaganian CL, Painter NA, Watanabe JH, Lee KC, Daniels CD, Morello CM -
Examining the Pharmacist Labor Supply in the United States: Increasing Medication Use, Aging Society, and Evolution of Pharmacy Practice.
Pharmacy (Basel, Switzerland) 2019 Watanabe JH -
Policy impact: When policy fails.
Nursing forum 2019 Davidson JE, Marshall MF, Watanabe JH -
Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults With Alzheimer Disease, 2013-2014.
The Annals of pharmacotherapy 2019 Sepassi A, Watanabe JH -
Anxiety and Depression Symptoms and Every-Night Sleep Medication Use in Older Adults.
The Senior care pharmacist 2019 Watanabe JH, Chau DL -
Medications for Opioid Use Disorder Save Lives
Medications for Opioid Use Disorder Save Lives 2019 -
Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series
Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series 2019 -
Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop—in Brief
Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop—in Brief 2018 -
Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2018 Nguyen HK, Humber D, Checkoway H, Blanchard D, Watanabe JH -
Medication Regimen Complexity in Long-Term Care Facilities and Adverse Drug Events-Related Hospitalizations.
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2017 Tam SHY, Hirsch JD, Watanabe JH -
An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013.
Research in social & administrative pharmacy : RSAP 2016 Bounthavong M, Li M, Watanabe JH -
Value of Information in Asia: Concepts, Current Use, and Future Directions.
Value in health regional issues 2016 Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD -
Association of increased emergency rooms costs for patients without access to necessary medications.
Research in social & administrative pharmacy : RSAP 2014 Watanabe JH, Ney JP -
Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
Journal of managed care pharmacy : JMCP 2014 Watanabe JH, Kazerooni R, Bounthavong M -
Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study.
The Annals of pharmacotherapy 2013 Watanabe JH, Bounthavong M, Chen T, Ney JP -
Association of copayment and statin adherence stratified by socioeconomic status.
The Annals of pharmacotherapy 2013 Kazerooni R, Bounthavong M, Watanabe JH -
Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
Pharmacotherapy 2013 Kazerooni R, Watanabe JH, Bounthavong M -
Cost-benefit analysis: intraoperative neurophysiological monitoring in spinal surgeries.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2013 Ney JP, van der Goes DN, Watanabe JH -
Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons.
Pain medicine (Malden, Mass.) 2013 Ney JP, Devine EB, Watanabe JH, Sullivan SD -
Cost-effectiveness of intraoperative neurophysiological monitoring for spinal surgeries: beginning steps.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2012 Ney JP, van der Goes DN, Watanabe JH -
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.
Drugs & aging 2011 Sand PK, Rovner ES, Watanabe JH, Oefelein MG -
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.
Urology 2010 Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD -
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.
BMC urology 2009 Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD